From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases: Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01) “The goal of this opportunity is to support innovative research in humans to elucidate the role of HIV infection, including relevant host conditions…
Two new NIH/NIDDK funding opportunities have become recently available: From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases: Research Using Biosamples and Subjects from Type 1 Diabetes Clinical Studies –Complications (DP3) “The NIDDK seeks to accelerate the pace of scientific research towards…
From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases: Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (DP3) “Clinical and observational studies indicate that real-time information…
From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases: Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (DP3) “New technologies for monitoring blood glucose, which provide detailed information about daily glucose patterns, are already in clinical use and are…
From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases: Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes NIH/NIDDK is seeking researchers to conduct advanced clinical trials to test the outpatient clinical safety and efficacy of artificial…
25.8 million men, women, and children in the United States have diabetes. That is 8.3% of the American population. 79 million more Americans are currently at risk for type 2 diabetes.
